Synkrino Biotherapeutics, Inc.
Biotechnology
Synkrino Biotherapeutics is a cutting-edge biotech firm based in Oakland, California, specializing in the development of novel therapeutics for diseases related to the immune system and inflammation. Leveraging its proprietary AI and Immunology Discovery Engine (AIDE), Synkrino Biotherapeutics aims to discover and develop biologically valid drug targets by analyzing immune tissue from patients. This innovative approach holds promise for creating effective treatments in areas critical to public health.
Founded: 2018
Jason Barbour, PhD Co-Founder and CEO |
David Ott Co-Founder and CTO |